Kanada - Kiingereza - Health Canada

vertex pharmaceuticals (canada) incorporated - ivacaftor - tablet - 150mg - ivacaftor 150mg - cystic fibrosis transmembrane conductance regulator potentiators

Kanada - Kiingereza - Health Canada

vertex pharmaceuticals (canada) incorporated - ivacaftor - granules - 50mg - ivacaftor 50mg - cystic fibrosis transmembrane conductance regulator potentiators

Kanada - Kiingereza - Health Canada

vertex pharmaceuticals (canada) incorporated - ivacaftor - granules - 75mg - ivacaftor 75mg - cystic fibrosis transmembrane conductance regulator potentiators

Kanada - Kiingereza - Health Canada

vertex pharmaceuticals (canada) incorporated - ivacaftor - granules - 25mg - ivacaftor 25mg - cystic fibrosis transmembrane conductance regulator potentiators

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

med & surgical requisites pty ltd - 16584 - suture, polydioxanone - it is a monofilament synthetic absorbable suture composed of poly-p-dioxanon and available dyed and undyed. absorption is complete after about 210 days. intended for use in general soft tissue approximation and/or ligation and should not be used in cases where an extended wound support over a period of 6 weeks is desirable. assucryl monoslow can also be used in paediatric cardiovascular surgery, microsurgery and ophthalmologic surgery.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

johnson & johnson medical pty ltd - 16584 - suture, polydioxanone - absorbable, monofilament, synthetic, sterile, surgical suture prepared from the polyester, poly(p-dioxanone). available undyed clear and dyed violet to enhance visibilty in tissue. available with or without needles. indicated for use in general tissue approximation, including use in paediatric cardiovascular tissue where growth is expected to occur and ophthalmic surgery.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

boston scientific pty ltd - 34598 - suture, absorbable - the suture is placed using a needle holder to drive the needle through the tissue. the needle point is then removed and the suture tied using standard surgical procedure. these sutures are gradually encapsulated by fibrous connective tissue before eventually being absorbed by means of hydrolysis. this suture is supplied sterile, dyed (violet) in size 0 (metric size 3.5)in a 48 inch length with a tc tapercut needle. this suture is intended for use with the capio suturing device the monodek polydioxanone monofilament absorbable suture is indicated for use is soft tissue approximation. it is not indicated in adult cardiovascular tissue, microsurgery or neural tissue. these sutures are particularly useful where the combination of an absorbable suture and extended wound support (up to 6 weeks) is desirable.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

johnson & johnson medical pty ltd t/a depuy synthes - 16584 - suture, polydioxanone - orthocord sutures are indicated for use in general soft tissue approximation and or ligation, including orthopeadic procedures orthocord sutures are indicated for use in general soft tissue approximation and or ligation, including orthopeadic procedures

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

drbc cosmetics pty ltd atf the drbc trust - 46859 - lift thread, absorbable - a sterile single- use polydioxanone suture with needle. the thread is slowly hydrolysed and absorbed by the body over 60-90 days. cog types contain barbs in different patterns and various distances between repeating patterns which are tacked to deep fascia where the projections produce tension for elevation of the subdermis. consists of suture, sponge, cannula, hub, protect cap. the absorbable polydioxanone suture with needle is intended use for the treatment of cheek laxity and improvement of nasolabial folds and facial soft tissue reconstruction in the asymmetry. indicated for skin rejuvenation, wrinkle improvement.